In mammary carcinoma cells, the NOS inhibitor, L-NNA, increased the BH4:BH2 ratio indicating that NOS generated ROS/RNS was, in part, responsible for the low BH4:BH2 ratio (17). The gene discussed is NOS1; the disease is breast carcinoma.